The global cannabidiol market size was valued at USD 9.95 billion in 2025 and is projected to grow from USD 11.55 billion in 2026 to USD 38.07 billion by 2034, registering a CAGR of 16.08% during the forecast period from 2026 to 2034. North America dominated the cannabidiol market with a market share of 42% in 2025.
Cannabidiol (CBD) is a natural compound extracted from the hemp plant that is widely used in wellness, personal care, pharmaceutical, and nutraceutical products. It is commonly found in oils, capsules, creams, beverages, and supplements. Demand is growing due to increasing consumer interest in natural wellness products, expanding research on CBD applications, and changing regulations supporting the use of hemp-derived products.
Download a Free Sample To learn more about this report,
Expansion of CBD Applications Beyond Traditional Wellness Products
The CBD market is diversifying beyond oils and tinctures into topical products, beverages, personal-care formulations, pet products, and pharmaceutical applications. This broader product development is allowing CBD suppliers to address different consumer preferences and usage formats while increasing the number of channels through which cannabidiol can reach end users. However, product positioning increasingly depends on distinguishing wellness-oriented applications from regulated therapeutic uses.
In April 2025, the U.S. FDA issued warning letters involving multiple CBD products marketed for animal and human uses, reflecting the continued expansion of CBD formulations across consumer and veterinary categories.
Increasing Focus on Pharmaceutical-Grade Cannabidiol
Pharmaceutical applications are becoming an important segment of CBD development as clinical research and regulatory approvals distinguish standardized cannabidiol medicines from broadly marketed consumer products. Pharmaceutical-grade CBD benefits from controlled formulation, defined dosing, manufacturing requirements, and evidence-based indications, creating a more regulated pathway for cannabidiol commercialization.
In July 2020, the U.S. FDA expanded the approved labeling of Epidiolex, a purified cannabidiol medicine, to include seizures associated with tuberous sclerosis complex in patients aged 1 year and older.
Growing Consumer Interest in Plant-Derived Wellness Ingredients
Consumer interest in plant-derived ingredients is supporting demand for CBD products positioned around general wellness and lifestyle applications. CBD's non-intoxicating profile compared with THC has also helped differentiate it within the broader cannabis-derived product landscape. This consumer interest is encouraging manufacturers to develop convenient formats and expand CBD availability through different retail and online channels.
In December 2017, the World Health Organization concluded that pure cannabidiol did not appear to have abuse potential or cause harm and recommended that it not be internationally scheduled as a controlled substance.
Regulatory Uncertainty Limits Mainstream Food and Supplement Adoption
Uncertainty surrounding the legal status and permissible uses of CBD remains a major constraint for manufacturers, retailers, and consumers. Regulatory treatment differs across countries and product categories, while restrictions on CBD in foods and dietary supplements can limit commercialization and increase compliance costs. Businesses must therefore navigate different requirements for pharmaceutical, cosmetic, food, and wellness applications.
In January 2023, the U.S. FDA concluded that existing regulatory frameworks for foods and dietary supplements were not appropriate for CBD and stated that a new regulatory pathway would be needed.
Development of Evidence-Based CBD Therapeutics
Clinical research and pharmaceutical development create opportunities to move CBD toward applications supported by defined indications, standardized dosing, and medical supervision. The established regulatory pathway for prescription cannabidiol demonstrates that specific CBD formulations can achieve therapeutic authorization when supported by appropriate safety and efficacy evidence. Further research into neurological and other conditions could expand the addressable pharmaceutical segment.
In September 2018, the U.S. FDA approved Epidiolex as a purified cannabidiol treatment for seizures associated with Lennox-Gastaut syndrome and Dravet syndrome in patients aged 2 years and older.
Increasing Need for Product Quality and Safety Control
Variability in formulation, concentration, labeling, and manufacturing practices can create challenges for CBD suppliers seeking to establish consistent product quality. Safety concerns also require greater attention to dosing, drug interactions, potential liver effects, and contaminant control. Stronger testing and quality-management systems are therefore necessary to differentiate compliant products from inadequately characterized formulations.
In April 2025, the U.S. FDA issued multiple warning letters concerning CBD products, including products marketed for human and animal use, demonstrating continued regulatory enforcement against products making unauthorized or unsupported claims.
Hemp Segment Dominated the Market with 68% Share in 2025
The hemp segment dominated the global cannabidiol (CBD) market with a 68% share in 2025. Hemp-derived CBD remains the preferred source because it contains low levels of THC, complies with regulations in many countries, and is widely used in wellness, personal care, and healthcare products. Growing consumer demand for plant-based wellness products continues to strengthen the segment's leading position.
The marijuana segment is also growing steadily as regulatory changes in several countries expand access to medical cannabis products. Increasing research into therapeutic applications and rising acceptance of cannabis-based treatments are expected to support growth across both source segments.
Request Customizationto receive a tailored report.
CBD Oil Segment Dominated the Market with 34% Share in 2025
The CBD oil segment dominated the global cannabidiol (CBD) market with a 34% share in 2025. CBD oil is the most widely used product because it is easy to consume, available in different strengths, and commonly used for wellness, relaxation, and therapeutic purposes. Its versatility and broad consumer acceptance continue to support the segment's leading position.
The CBD topicals, CBD capsules, CBD tinctures, CBD vape products, and others segments are also witnessing steady growth. Topicals are increasingly used in skincare and pain relief products, capsules offer convenient daily supplementation, tinctures provide flexible dosing, and vape products remain popular among selected consumer groups. Product innovation and expanding retail availability continue to drive demand across all product categories.
Pharmaceutical Segment Dominated the Market with 22% Share in 2025
The pharmaceutical segment dominated the global cannabidiol (CBD) market with a 22% share in 2025. CBD is increasingly being incorporated into pharmaceutical products due to growing research into its potential therapeutic applications. Rising investment in cannabinoid-based medicines and increasing regulatory approvals continue to strengthen this segment.
The tincture, topicals, dietary supplements, food, beverages, and others segments are also growing steadily. Consumers are increasingly using CBD in wellness products, functional foods, beverages, skincare formulations, and nutritional supplements as awareness of CBD-based products continues to rise.
Growing product innovation and expanding consumer interest in health and wellness are expected to support demand across all application segments.
Online Segment Dominated the Market with 58% Share in 2025
The online segment dominated the global cannabidiol (CBD) market with a 58% share in 2025. Online sales remain the preferred distribution channel because they provide consumers with greater product variety, competitive pricing, convenient home delivery, and easy access to product information. The rapid growth of e-commerce and direct-to-consumer platforms continues to strengthen the segment's leading position.
The offline segment is also growing steadily through pharmacies, specialty wellness stores, supermarkets, and dispensaries. Many consumers continue to prefer purchasing CBD products from physical stores where they can receive product guidance and verify product quality before making a purchase.
The continued expansion of e-commerce platforms, improving retail availability, and increasing consumer awareness are expected to support long-term growth across both online and offline distribution channels.
Speak to an Analystto discuss market opportunities.
North America cannabidiol (CBD) market accounted for 42% of the global market, reaching USD 4.18 billion in 2025, and is projected to grow at a CAGR of 14.5% during the forecast period. The market is growing rapidly because of increasing consumer awareness of CBD-based wellness products, expanding legalization in several regions, and rising demand for natural health supplements. Product innovation and wider retail availability are also supporting market growth.
The US market was valued at USD 3.55 billion in 2025, making it the largest contributor in North America. Growing demand for CBD oils, edibles, and personal care products, along with increasing consumer awareness of plant-based wellness solutions, continues to drive market growth.
Canada's market reached USD 0.63 billion in 2025. Favorable regulatory policies, increasing adoption of CBD wellness products, and expanding retail distribution continue to support steady market growth.
Unlock Regional Insightsto access country-level data, & regional trends.
Europe cannabidiol (CBD) market accounted for 28% of the global market, reaching USD 2.79 billion in 2025, and is expected to register a CAGR of 17.8% during the forecast period. Rising demand for plant-based health products, growing consumer awareness, and increasing investment in CBD product development are supporting market growth. Expanding online sales and retail availability are also contributing to regional expansion.
Germany's market accounted for USD 0.81 billion in 2025. Strong consumer demand for wellness products, increasing availability of CBD-based supplements, and a well-developed healthcare sector continue to support market growth.
The UK market was valued at USD 0.56 billion in 2025. Rising interest in natural wellness products, increasing online sales, and growing acceptance of CBD-based personal care items continue to contribute to market growth.
Asia Pacific cannabidiol (CBD) market accounted for 18% of the global market, valued at USD 1.79 billion in 2025, and is projected to register a CAGR of 15.9% during the forecast period. Growing consumer awareness, increasing investment in hemp-based products, and expanding research into CBD applications are driving market growth across the region. Rising disposable incomes and improving retail access are also creating new opportunities.
Japan's market generated USD 0.32 billion in 2025. Increasing demand for wellness products, growing consumer interest in natural ingredients, and expanding product availability continue to support market growth.
China's market accounted for USD 0.93 billion in 2025, representing the largest share within Asia Pacific. Strong hemp production capabilities, growing exports, and increasing investment in CBD research and manufacturing continue to drive market growth.
Middle East & Africa cannabidiol (CBD) market accounted for 5% of the global market, totaling USD 0.50 billion in 2025, and is anticipated to grow at a CAGR of 12.7% during the forecast period. Growing awareness of plant-based wellness products, increasing healthcare investments, and gradual regulatory developments are supporting market growth across the region.
The UAE market was valued at USD 0.18 billion in 2025. Rising demand for premium wellness products, increasing investment in healthcare, and expanding consumer interest in natural personal care solutions continue to support market growth.
Customize This Report to Match Your Strategic Objectives
Author's Details
Research Analyst
Preeti Bhagat is a research professional with around 2.5 years of experience in the market research industry, specializing in market analysis, secondary research, market estimation, forecasting, and competitive intelligence. She has developed expertise across industries including Packaging and Consumer Goods, supporting businesses with data-driven insights into market dynamics, industry trends, competitive landscapes, and growth opportunities.
Her experience includes conducting comprehensive secondary research, market sizing, demand analysis, company profiling, competitive benchmarking, and trend assessment. She has hands-on experience with structured research methodologies, including top-down and bottom-up approaches, to assess market potential, growth opportunities, and future market performance.
K-Beauty Products Market Size, Share, Growth, Forecast, 2034
Beauty and Personal Care Products Market Size, Share, Growth, 2034
Organic Skin Care Market Size, Share, Growth, Forecast, 2034
Men’s Grooming Products Market Size, Share, Growth, Analysis, 2034
Toothpaste Market Size, Share, Growth, Analysis, Report, 2034
Anti-aging Products Market Size, Share, Growth, Analysis, 2034
We are featured on:
sales@straitsresearch.com